UBS AM
OCGN icon

UBS AM’s Ocugen OCGN Stock Holding History

UBS AM’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-157,292
Closed -$204K – 2702
2022
Q4 		$204K Sell
157,292
-155,695
-50% -$243K ﹤0.01% 2441
2022
Q3 		$557K Hold
312,987
– – ﹤0.01% 2297
2022
Q2 		$710K Buy
312,987
+94,553
+43% +$226K ﹤0.01% 2141
2022
Q1 		$721K Buy
218,434
+18,391
+9% +$64.6K ﹤0.01% 2301
2021
Q4 		$910K Buy
200,043
+13,888
+7% +$105K ﹤0.01% 2261
2021
Q3 		$1.34M Buy
186,155
+9,133
+5% +$67K ﹤0.01% 2020
2021
Q2 		$1.42M Buy
+177,022
New +$1.49M ﹤0.01% 2009

Other funds holding OCGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

UBS AM's OCGN Position: Q1 2023 in Review

UBS AM sold out of Ocugen (OCGN) in Q1 2023, closing a stake of 157,292 shares — an estimated $204K sold.

UBS AM first reported a position in OCGN in Q2 2021 and held it in 7 quarters. The position peaked at $1.42M in Q2 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • UBS AM reported no remaining Ocugen position as of Q1 2023 after selling out during the quarter.
  • UBS AM sold 157,292 Ocugen shares in Q1 2023, an estimated $204K.
  • UBS AM first reported a position in Ocugen in Q2 2021 and held it in 7 quarters.
  • UBS AM's Ocugen position peaked at $1.42M in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.